ema semaglutide naion label update 2025 Novo's Ozempic linked to rare cases of serious eye disorder, EU regulator says EMA Warns of Vision Risk

Slower transit can also increase reflux or produce delayed sensations when gastric contents finally move into the intestine, further irritating the gastrointestinal tract

The FDA has approved weekly semaglutide injections for chronic weight management in obese or overweight adults with at least one weight-related condition

While science keeps moving forward, many questions still need answers

Ikemoto, S., Takahashi, M., Tsunoda, N., Maruyama, K., Itakura, H., & Ezaki, O

However, these current findings indicate that long-term GPLC supplementation at the higher dosages examined (3.0 and 4.5 g/d) did not result in greater values of power output but rather lower mean values of PP and MP